Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-29

Clinical Trial Update: Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of glucagon with an advanced hybrid closed-loop insulin delivery system to prevent exercise-induced hypoglycemia in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Type 1 Diabetes, Hypoglycemia | NA | Status: COMPLETED | Results posted: 2025-08-29